Loading
institutionsInstitution
Advanced Research Projects Agency for Health
The US agency modelled on DARPA that funds high-risk, milestone-driven health programmes, including adaptive cancer therapy, rapid tumour-removal surgery and early detection.
Also called: ARPA-H
Overview
Created in 2022 within the Department of Health and Human Services, ARPA-H funds programme managers to run time-limited, milestone-based projects that the NIH grant system does not, with an appropriation of roughly $1.5 billion per year in its first years. Cancer-relevant programmes include ADAPT (adaptive therapies that anticipate tumour evolution), POSEIDON (at-home multi-cancer screening), CUREIT (curative immunotherapy), Precision Surgical Interventions (removing all tumour tissue in one operation) and the Cancer Moonshot-aligned biomanufacturing efforts. It works through ARPANET-H hubs in Massachusetts, Texas and Washington and contracts rather than grants. Its model has drawn interest from other countries designing their own ARPA-style funders.
Location
Washington, DC, US
Type
government
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#324 · 20 points (0 Newsweek + 0 NCI + 20 from 10 linked objects) · ranking
- ADAPT (adaptive cancer therapy)
- POSEIDON (at-home multi-cancer screening)
- CUREIT and Precision Surgical Interventions
- ARPANET-H hub network
Similar pages
- PersonBehnam Badie
- IdeaA cancer blood test for older people arriving at A&E with unexplained symptoms
Shares Multi-cancer early detection (MCED), The hardest cancers are found late.
- IdeaPublish per-patient trial cost benchmarks and target halving them
Shares Funding follows fashion, not burden, National Cancer Institute (NIH).
- IdeaRandomised trials of how to spread proven cancer treatments, not just what works
Shares Funding follows fashion, not burden, National Cancer Institute (NIH).
- IdeaA public registry of unanswered clinical questions linked to funding calls
Shares Funding follows fashion, not burden, National Cancer Institute (NIH).
- PersonNancy Brinker
Shares Funding follows fashion, not burden, The hardest cancers are found late.
- IdeaReal-time margin assessment and image-guided surgery as the global standard
Shares Fluorescence-guided surgery, Surgery and radiotherapy cure most, get least.
- IdeaRing-fence a fifth of national cancer research money for metastasis
Shares Funding follows fashion, not burden, National Cancer Institute (NIH).